查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613310

去礦骨基質市場：按產品、劑型、應用和最終用途 - 2025-2030 年全球預測

Demineralized Bone Matrix Market by Product (Gel, Putty, Putty Combined with Cancellous Chips), Administration Mode (Implantation, Injection), Application, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年脫礦骨基質市場價值為6.7114億美元，預計到2024年將達到7.1336億美元，複合年成長率為6.54%，預計到2030年將達到10.4637億美元。

脫礦骨基質（DBM）是整形外科和重組手術必需的生物材料，由透過同種異體骨脫礦獲得的膠原蛋白、骨蛋白和生長因子組成。 DBM的主要應用是促進骨誘導、促進骨再生，對於脊椎融合手術、創傷修復、骨缺損等至關重要。 DBM 的應用非常廣泛，包括脊椎手術、牙科手術和關節重組，最終用途包括醫院、專科診所和研究機構。影響 DBM 市場的主要成長要素包括整形外科疾病盛行率的上升、老年人口的增加、再生醫學的進步以及對新手術技術認知的提高。此外，對微創手術的需求正在推動市場擴張。潛在的機會可能在於擴大產品線、將 DBM 與 3D 列印等先進技術相結合，以及進入醫療保健基礎設施快速發展的新興市場。然而，DBM產品的高價格、嚴格的法律規範以及同種異體移植疾病傳播的風險等挑戰也可能阻礙成長。此外，來自合成骨移植替代品的競爭也增加了額外的壓力。創新領域包括開發具有更高骨誘導性的 DBM、探索與生物活性材料的組合以提高功效，以及最佳化製造流程以提高成本效率。該市場的特點是競爭重點放在產品差異化和技術進步的研發、合作和夥伴關係關係。為了業務成長，建議建立強大的銷售網路並在研究方面形成策略聯盟，以開發下一代 DBM 產品。持續監控監管變化和報銷趨勢對於駕馭這個充滿活力的市場也至關重要。

主要市場統計
基準年[2023] 67114萬美元
預計年份 [2024] 71336萬美元
預測年份 [2030] 10.4637 億美元
複合年成長率（%） 6.54%

市場動態：快速發展的脫礦骨基質市場的關鍵市場洞察

供需的動態交互作用正在改變去礦骨基質市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 骨損傷的增加和整形外科手術的普及
    • 政府投資促進整形外科研究活動
  • 市場限制因素
    • 去礦骨基質的高成本和報銷限制
  • 市場機會
    • 脫礦骨基質材料的研究進展
    • 相關人員之間的合作以供應脫礦質骨基質
  • 市場挑戰
    • 對脫礦骨基質的品質和一致性的擔憂

波特五力：駕馭脫礦骨基質市場的策略工具

波特的五力框架是了解脫礦骨基質市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解脫礦骨基質市場的外部影響

外部宏觀環境因素在塑造脫礦骨基質市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解脫礦骨基質市場的競爭格局

對脫礦骨基質市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣去礦骨矩陣市場供應商的績效評估

FPNV定位矩陣是評估去礦骨基質市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃去礦骨基質市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，脫礦骨基質市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 骨損傷的增加和整形外科手術的引入
      • 政府投資促進整形外科研究活動
    • 抑制因素
      • 去礦骨基質的高成本和報銷限制
    • 機會
      • 脫礦骨基質材料的研究進展
      • 相關人員之間在脫礦骨基質供應方面的合作
    • 任務
      • 對脫礦骨基質的品質和一致性的擔憂
  • 市場區隔分析
    • 產品：在各種骨骼修復情況下採用膩子與 DBM 的鬆質骨碎片結合
    • 應用：DBM在整形外科手術的快速實施
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章脫礦骨基質市場：依產品

  • 凝膠
  • 油灰
  • 膩子和海綿碎片的組合

第7章依管理模式分類的脫鈣骨基質市場

  • 移植
  • 注射

第8章脫礦骨基質市場：依應用分類

  • 顱顎顏面外科
  • 牙齒重組
  • 關節重組
  • 整形外科修復
  • 脊椎融合手術

第9章脫礦骨基質市場：依最終用途分類

  • 醫院
  • 專科診所

第10章美洲脫礦骨基質市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區去礦骨基質市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲脫鈣骨基質市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Paragon 28 推出 BEAST 皮質纖維，擴大生技藥品產品組合
    • Biogenics 推出 Osteospan 纖維基質
    • Geistlich 宣布大幅擴展同種異體移植產品組合
  • 戰略分析和建議

公司名單

  • Advanced Biotech Products P Ltd
  • AlloSource
  • Arthrex, Inc.
  • Bioventus LLC
  • Cerapedics.Inc.
  • Curasan AG
  • Exactech, Inc.
  • Geistlich Pharma AG
  • Globus Medical
  • HansBioMed.
  • Institut Straumann AG
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin SE & Co. KG
  • Kuros Biosciences Ltd.
  • Medtronic PLC
  • NovaBone by Halma PLC
  • Orthofix Medical Inc.
  • Osteogenics Biomedical
  • RTI Surgical Holdings, Inc.
  • SpineWave, Inc.
  • Stryker Corporation
  • Synerheal
  • XTANT Medical
  • Zimmer Biomet
Product Code: MRR-F97DD5A7D66F

The Demineralized Bone Matrix Market was valued at USD 671.14 million in 2023, expected to reach USD 713.36 million in 2024, and is projected to grow at a CAGR of 6.54%, to USD 1,046.37 million by 2030.

Demineralized Bone Matrix (DBM) is a vital biomaterial in orthopedic and reconstructive surgery, composed of collagen, bone proteins, and growth factors derived through the decalcification of allograft bone. Its primary necessity lies in promoting osteoinduction and enhancing bone regeneration, essential in spinal fusions, trauma repair, and bone defects. DBM's application is vast, utilized in spine surgery, dental surgeries, and joint reconstruction, with its end-use scope spanning hospitals, specialty clinics, and research institutes. Key growth factors influencing the DBM market include the rising prevalence of orthopedic disorders, increasing geriatric population, advancements in regenerative medicine, and growing awareness of novel surgical techniques. Moreover, the demand for minimally invasive surgeries fosters market expansion. Potential opportunities can be found in the expansion of product lines, integration of DBM with advanced technologies like 3D printing, and entering emerging markets where healthcare infrastructure is evolving rapidly. However, challenges exist, such as the high cost of DBM products, stringent regulatory frameworks, and risks of disease transmission from allograft sources, which may hinder growth. Furthermore, the competition from synthetic bone graft substitutes adds additional pressure. Innovation areas include the development of DBM with enhanced osteoinductive properties, exploring its combination with bioactive materials for greater efficacy, and optimizing manufacturing processes for cost efficiency. The market is characterized by its competitive nature with a focus on R&D, collaborations, and partnerships aimed at product differentiation and technological advancements. For business growth, strategic partnerships in research for developing next-generation DBM products, alongside establishing a robust distribution network, are recommended. Continual monitoring of regulatory changes and reimbursement trends is also critical to navigating this dynamic market.

KEY MARKET STATISTICS
Base Year [2023] USD 671.14 million
Estimated Year [2024] USD 713.36 million
Forecast Year [2030] USD 1,046.37 million
CAGR (%) 6.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Demineralized Bone Matrix Market

The Demineralized Bone Matrix Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of bone injuries and adoption of orthopedic surgeries
    • Government investments promoting orthopedic research activities
  • Market Restraints
    • High cost and reimbursement limitations of demineralized bone matrix
  • Market Opportunities
    • Advancements in the demineralized bone matrix materials
    • Collaboration between stakeholders for supply of demineralized bone matrix
  • Market Challenges
    • Quality and consistency concerns of demineralized bone matrix

Porter's Five Forces: A Strategic Tool for Navigating the Demineralized Bone Matrix Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Demineralized Bone Matrix Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Demineralized Bone Matrix Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Demineralized Bone Matrix Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Demineralized Bone Matrix Market

A detailed market share analysis in the Demineralized Bone Matrix Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Demineralized Bone Matrix Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Demineralized Bone Matrix Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Demineralized Bone Matrix Market

A strategic analysis of the Demineralized Bone Matrix Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Demineralized Bone Matrix Market, highlighting leading vendors and their innovative profiles. These include Advanced Biotech Products P Ltd, AlloSource, Arthrex, Inc., Bioventus LLC, Cerapedics.Inc., Curasan AG, Exactech, Inc., Geistlich Pharma AG, Globus Medical, HansBioMed., Institut Straumann AG, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., KLS Martin SE & Co. KG, Kuros Biosciences Ltd., Medtronic PLC, NovaBone by Halma PLC, Orthofix Medical Inc., Osteogenics Biomedical, RTI Surgical Holdings, Inc., SpineWave, Inc., Stryker Corporation, Synerheal, XTANT Medical, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Demineralized Bone Matrix Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Gel, Putty, and Putty Combined with Cancellous Chips.
  • Based on Administration Mode, market is studied across Implantation and Injection.
  • Based on Application, market is studied across Craniomaxillofacial Surgeries, Dental Reconstructions, Joint Reconstruction, Orthopedic Repairs, and Spinal Fusion Surgery.
  • Based on End-Use, market is studied across Hospitals and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of bone injuries and adoption of orthopedic surgeries
      • 5.1.1.2. Government investments promoting orthopedic research activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and reimbursement limitations of demineralized bone matrix
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the demineralized bone matrix materials
      • 5.1.3.2. Collaboration between stakeholders for supply of demineralized bone matrix
    • 5.1.4. Challenges
      • 5.1.4.1. Quality and consistency concerns of demineralized bone matrix
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Adoption of putty combined with cancellous chips form of DBM for extensive bone repair situations
    • 5.2.2. Application: Exponential adoption of DBM for orthopedic surgical procedures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Demineralized Bone Matrix Market, by Product

  • 6.1. Introduction
  • 6.2. Gel
  • 6.3. Putty
  • 6.4. Putty Combined with Cancellous Chips

7. Demineralized Bone Matrix Market, by Administration Mode

  • 7.1. Introduction
  • 7.2. Implantation
  • 7.3. Injection

8. Demineralized Bone Matrix Market, by Application

  • 8.1. Introduction
  • 8.2. Craniomaxillofacial Surgeries
  • 8.3. Dental Reconstructions
  • 8.4. Joint Reconstruction
  • 8.5. Orthopedic Repairs
  • 8.6. Spinal Fusion Surgery

9. Demineralized Bone Matrix Market, by End-Use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinics

10. Americas Demineralized Bone Matrix Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Demineralized Bone Matrix Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Demineralized Bone Matrix Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Paragon 28 Launches BEAST Cortical Fibers Expanding its Biologics Portfolio
    • 13.3.2. Biogennix Launches OsteoSPAN Fiber Matrix
    • 13.3.3. Geistlich Announces The Dramatic Expansion Of Their Allograft Portfolio
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Biotech Products P Ltd
  • 2. AlloSource
  • 3. Arthrex, Inc.
  • 4. Bioventus LLC
  • 5. Cerapedics.Inc.
  • 6. Curasan AG
  • 7. Exactech, Inc.
  • 8. Geistlich Pharma AG
  • 9. Globus Medical
  • 10. HansBioMed.
  • 11. Institut Straumann AG
  • 12. Integra LifeSciences Holdings Corporation
  • 13. Johnson & Johnson Services, Inc.
  • 14. KLS Martin SE & Co. KG
  • 15. Kuros Biosciences Ltd.
  • 16. Medtronic PLC
  • 17. NovaBone by Halma PLC
  • 18. Orthofix Medical Inc.
  • 19. Osteogenics Biomedical
  • 20. RTI Surgical Holdings, Inc.
  • 21. SpineWave, Inc.
  • 22. Stryker Corporation
  • 23. Synerheal
  • 24. XTANT Medical
  • 25. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. DEMINERALIZED BONE MATRIX MARKET RESEARCH PROCESS
  • FIGURE 2. DEMINERALIZED BONE MATRIX MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DEMINERALIZED BONE MATRIX MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DEMINERALIZED BONE MATRIX MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEMINERALIZED BONE MATRIX MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEMINERALIZED BONE MATRIX MARKET DYNAMICS
  • TABLE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PUTTY COMBINED WITH CANCELLOUS CHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY IMPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY DENTAL RECONSTRUCTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ORTHOPEDIC REPAIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPINAL FUSION SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY ADMINISTRATION MODE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DEMINERALIZED BONE MATRIX MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 191. DEMINERALIZED BONE MATRIX MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. DEMINERALIZED BONE MATRIX MARKET, FPNV POSITIONING MATRIX, 2023